Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · opportunities

PumasAI Brings AI, Scientific Machine Learning and Advanced Pharmacometric Research ...

2 October 2026 · By · Wire by Fusion42

Published

2 October 2026

Topic

opportunities

◆ Sectors

Biotech

◆ Geography

United States

◆ Source

Read at firstwordpharma.com →

◆ Verified

Fusion42 · 2 October 2026 · Fusion42 review

PumasAI is showcasing its AI-driven pharmacometrics innovations at ACoP 2026, including a full-day workshop on AI in pharmacometrics and four scientific poster presentations highlighting advanced AI-enabled drug development modeling.

This Wire brief sits within Fusion42's coverage of Biotech.

◆ ◆ The Wire takeaway

You must engage with AI-driven pharmacometric tools to stay ahead as PumasAI proves these innovations can speed up drug development decisions. Missing this shift risks falling behind pharma teams adopting smarter, faster modelling strategies.

◆ Coverage

1 source · 2 Oct 2026

◆ Related on Wire

◆ Topics

Biotechaipharmacometricsdrug-developmentscientific-machine-learninghealthtech